Cepheid Management to Present at the 7th Annual Needham Medical Technology and Biotechnology Conference and William Blair's 28th Annual Growth Stock Conference

SUNNYVALE, Calif., June 4 Cepheid (Nasdaq: CPHD)announced today that the Company will webcast presentations at the followinginvestor conferences:

Andrew Miller, Senior Vice President, Chief Financial Officer, DavidPersing, Executive Vice President, Chief Medical and Technology Officer, andRob Koska, Senior Vice President, Worldwide Commercial Operations, willprovide a corporate overview at each of the conferences.

In the webcast presentations, Cepheid will provide an update on its testpipeline strategy through fiscal 2013.

Live webcasts, along with accompanying presentation slides, may beaccessed on Cepheid's Web site at http://www.cepheid.com under Investors:Events: Webcasts and Presentations. A replay of the webcast presentations willbe available for 90 days following the live events. The updated investorpresentation is now available for viewing on Cepheid's Web site underInvestors.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a moleculardiagnostics company that develops, manufactures, and markets fully-integratedsystems and tests for genetic analysis in the clinical, industrial andbiothreat markets. The company's systems enable rapid, sophisticated genetictesting for organisms and genetic-based diseases by automating otherwisecomplex manual laboratory procedures. The company's easy-to-use systemsintegrate a number of complicated and time-intensive steps, including samplepreparation, DNA amplification and detection, which enable the analysis ofcomplex biological samples in its proprietary test cartridges. Through itsstrong molecular biology capabilities, the company is focusing on thoseapplications where rapid molecular testing is particularly important, such asidentifying infectious disease and cancer in the clinical market; food,agricultural, and environmental testing in the industrial market; andidentifying bio-terrorism agents in the biothreat market. Seehttp://www.cepheid.com for more information.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU101LOGO)-- The 7th Annual Needham Medical Technology and Biotechnology Conference on June 11 at 2:30 p.m. ET at the Millennium Broadway Hotel in New York -- William Blair's 28th Annual Growth Stock Conference on June 18 at 4:50 p.m. ET at the Four Seasons Hotel in Chicago

SOURCE Cepheid

Latest Press Release on General News

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...

Dr. Andres Bustillo Responds to Miami's Growing Interest in Facelift Procedures

In response to the growing demand for facelifts in Miami , Dr. Andres Bustillo , a renowned board-certified facial plastic surgeon, is offering advanced and time-proven techniques in f...

Deepening the Partnership: Dawn Health Introduces Ekiva for Enhanced Disease Management of Paroxysmal Nocturnal Hemoglobinuria (PNH)

COPENHAGEN, Denmark , April 8, 2024 /PRNewswire/ -- Building upon their partnership announced last year, digital health leader Dawn Health and global pharmaceutical company Nov...